Lotus Labs enters stability studies business

Lotus Labs, a Bangalore-based contract research organisation (CRO), has moved into the sphere of drug stability studies, which measure how the quality of a drug substance varies with time under the influence of temperature, humidity and light.

"After building skills in bio-analytical, clinical research, we are now fully geared to take up drug stability studies for pharmaceutical companies," said Sudhir Pai, director commercial at Lotus Labs.

Currently, the company plans to take up stability studies for its parent company Iceland-based Actavis group, which is the fourth largest generic pharmaceutical company.

"After stabilising the operations in another 6-8 months, we plans to take up third party assignments," he added.